Media

CELLAAX COMPLETES PHASE 1 TRIAL FOR GENETIC BLINDNESS USING CELLULAR THERAPY

CELLAAX Malaysia, a biopharmaceutical company engaged in the research and development of cellular therapy, recently completed its Phase 1 clinical trials to treat Retinitis Pigmentosa – a form of hereditary blindness that affects approximately two million people worldwide. The Phase 1 clinical trials which comprised 2 case studies, began in November 2020 and has since delivered promising results to move to phase 2 clinical trials.

Read More »
TitleImageLink
Mesenchymal Stem Cell Therapy for Alzheimer’s DiseaseMesenchymal Stem Cell Therapy for Alzheimer’s DiseaseDownload
Mesenchymal Stem Cells from the Wharton’s Jelly of the Human Umbilical Cord: Biological Properties and Therapeutic PotentialMesenchymal Stem Cells from the Wharton’s Jelly of the Human Umbilical Cord: Biological Properties and Therapeutic PotentialDownload
Common Expression of Stemness Molecular Markers and Early Cardiac Transcription Factors in Human Wharton’s Jelly-Derived Mesenchymal Stem Cells and Embryonic Stem CellsCommon Expression of Stemness Molecular Markers and Early Cardiac Transcription Factors in Human Wharton’s Jelly-Derived  Mesenchymal Stem Cells and Embryonic Stem CellsDownload
A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus ErythematosusA Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus ErythematosusDownload
Mesenchymal Stem Cell Injections Improve Symptoms of Knee OsteoarthritisMesenchymal Stem Cell Injections Improve Symptoms of  Knee OsteoarthritisDownload
Enhancement of Tendon Graft Osteointegration Using Mesenchymal Stem Cells in a Rabbit Model of Anterior Cruciate Ligament ReconstructionEnhancement of Tendon Graft Osteointegration Using Mesenchymal Stem Cells in a Rabbit Model of Anterior  Cruciate Ligament ReconstructionDownload
Anterior cruciate ligament constructs fabricated from human mesenchymal stem cells in a collagen type I hydrogelAnterior cruciate ligament constructs fabricated from human mesenchymal stem cells in a collagen  type I hydrogelDownload
Clinical effect of subcutaneous application of Cellmax® on treating chronic wounds: a case seriesClinical effect of subcutaneous application of Cellmax® on treating chronic wounds: a case seriesDownload
Subtenon implantation of wharton’s jelly-derived mesenchymal stromal cells in retinitis pigmentosaSubtenon implantation of wharton’s jelly-derived mesenchymal stromal cells in retinitis pigmentosaDownload
Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of GlaucomaTherapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of GlaucomaDownload
Treatment of acute ischemic stroke by minimally manipulated umbilical cord-derived mesenchymal stem cells transplantation: A case reportTreatment of acute ischemic stroke by minimally manipulated umbilical cord-derived mesenchymal stem cells transplantation: A case reportDownload
Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety StudyAllogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety StudyDownload
Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditionsSafety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditionsDownload
Therapeutic Potential of HGF-Expressing Human Umbilical Cord Mesenchymal Stem Cells in Mice with Acute Liver FailureTherapeutic Potential of HGF-Expressing Human Umbilical Cord Mesenchymal Stem Cells in Mice with Acute Liver FailureDownload
Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson’s diseaseQuantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson’s diseaseDownload
Human umbilical cord blood stem cell transplantation for the treatment of chronic spinal cord injuryHuman umbilical cord blood stem cell transplantation for the treatment of chronic spinal cord injuryDownload
Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autismTransplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autismDownload
Human Umbilical Cord Mesenchymal Stem Cells Treatment Combined with Anti-Virus and other Treatments for COVID-19Human Umbilical Cord Mesenchymal Stem Cells Treatment Combined with  Anti-Virus and other Treatments for COVID-19Download
Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: Preliminary resultsEarly immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: Preliminary resultsDownload
Efficacy of Stem Cell Application in Diabetes Mellitus: Promising Future Therapy for Diabetes and Its ComplicationsEfficacy of Stem Cell Application in Diabetes Mellitus: Promising Future Therapy for Diabetes and Its ComplicationsDownload
Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trialIntracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trialDownload
Common Expression of Stemness Molecular Markers and Early Cardiac Transcription Factors in Human Wharton’s Jelly-Derived Mesenchymal Stem Cells and Embryonic Stem CellsCommon Expression of Stemness Molecular Markers and Early Cardiac Transcription Factors in Human Wharton’s Jelly-Derived  Mesenchymal Stem Cells and Embryonic Stem CellsDownload
Human umbilical cord blood-derived mononuclear cell transplantation: Case series of 30 subjects with Hereditary AtaxiaHuman umbilical cord blood-derived mononuclear cell transplantation: Case series of 30 subjects with Hereditary AtaxiaDownload
Mesenchymal stem cells transplantation for systemic lupus erythematosusMesenchymal stem cells transplantation for systemic lupus erythematosusDownload
A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus ErythematosusA Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus ErythematosusDownload
Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical studyUmbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical studyDownload
Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosisImmunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosisDownload
Therapeutic effects of human umbilical cord-derived mesenchymal stem cells against acute tubular necrosis quantified through measures of iNOS, BMP-7 and Bcl-2*Therapeutic effects of human umbilical cord-derived mesenchymal stem cells against acute tubular necrosis quantified through measures of iNOS, BMP-7 and Bcl-2*Download
Human cord blood-derived mononuclear cell transplantation for viral encephalitis-associated cognitive impairment: a case reportHuman cord blood-derived mononuclear cell transplantation for viral encephalitis-associated cognitive impairment: a case reportDownload

Subscribe